In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-16 of 16 for your search:
Drug:  ramucirumab
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13892, 2008-001727-65, TRIO-012, TRIO-CIRG-012, CP12-0606, I4T-IE-JVBC, NCT00703326
2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13893, 2008-005964-15, CP12-0715, I4T-IE-JVBD, NCT00917384
3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13921, 14T-IE-JVBP, CP12-0605, NCT00515697
4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13920, CP12-0604, NCT00533702
5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13922, CP12-0710, I4T-IE-JVBQ, NCT00627042
6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13924, CP18-0601, I4T-IE-JVBS, NCT00683475
7.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13923, 2007-006717-17, CP12-0711, I4T-IE-JVBR, NCT00721162
8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13914, 2007-006715-22, CP12-0708, I4T-IE-JVBJ, NCT00735696
9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13897, 2008-004936-19, CP12-0709, I4T-IE-JVBH, NCT00862784
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ABTC-0901 CDR0000641230, U01CA137443, ABTC-0901, IMCL-CP-19-0801, NCT00895180
11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13915, CP12-0712, I4T-IE-JVBK, NCT01017731
12.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E7208, E7208, NCT01079780
13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13898, CP12-0816, I4T-IE-JVBI, NCT01005355
14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 14204, CP12-1026, I4T-IE-JVBW, NCT01253525
15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 14200, CP12-1028, I4T-IE-JVBX, NCT01256567
16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 14223, CP12-1029, 14T-IE-JVBY, NCT01286818
New Search